Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity

Objective: Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in patients with systemic lupus erythematosus (SLE). Glycoprotein acetylation (GlycA), a novel biomarker for chronic inflammation, has been reported to be increased in several inflammatory diseases. We in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dierckx, Tim, Chiche, Laurent, Daniel, Laurent, Lauwerys, Bernard, Van Weyenbergh, Johan, Jourde-Chiche, Noémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230647/
https://www.ncbi.nlm.nih.gov/pubmed/32244481
http://dx.doi.org/10.3390/jcm9040970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230647/
https://www.ncbi.nlm.nih.gov/pubmed/32244481
http://dx.doi.org/10.3390/jcm9040970

Ejemplares similares